Sean Sachdev
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial (NCT06499870) | Sean Sachdev | 2024-09-06 |
Track Sean Sachdev automatically
Every clearance here is in the API, with alerts when new ones post.